Device / Technology News

RSS

Researchers create breathalyzer that may help control blood sugar

Finger pricks may soon be a thing of the past for diabetics. Researchers at Western New England University have created a breathalyzer that may help control blood sugar by measuring the amount of acetone in the breath.

27 Nov 2013

Current laser therapy approaches provide effective treatment for excessive scars

Current laser therapy approaches are effective for treating excessive scars resulting from abnormal wound healing, concludes a special topic paper in the December issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

27 Nov 2013

Penn Medicine incorporates automated prediction tool that aims to reduce hospital readmissions

An automated prediction tool which identifies newly admitted patients who are at risk for readmission within 30 days of discharge has been successfully incorporated into the electronic health record of the University of Pennsylvania Health System. The tool, developed by researchers at the Perelman School of Medicine, is the subject of a study published in the December issue of the Journal of Hospital Medicine.

27 Nov 2013

Novel micro-catheter fluorescent dye method to treat aneurysm in deep brain

In March 2013, Eric Wagner told his wife to call 9-1-1 because he was feeling the worst that he had ever felt. He was rushed by EMS to University Hospitals (UH) Ahuja Medical Center, and then airlifted to UH Case Medical Center, where brain scans showed that he had a ruptured aneurysm, a leaking blister on a blood vessel that was letting blood flow into his brain and causing a stroke.

27 Nov 2013

Bioaxial secures funds to market optical microscopy modules

Bioaxial, developers of super-resolved fluorescence microscopy for the extended imaging of live cells, today announces the completion of a EUR 1.9 million (USD 2.7 million) equity investment by three new large investors; Amorcage Technologique Investissement (a fund managed by CEA Investissement), Inserm Transfert Initiative and Viveris Management plus a range of individual investors.

27 Nov 2013

Genetics and cardiovascular drugs: an interview with Nancy Lurker, CEO of PDI and Paul Kinnon, CEO of Transgenomic, Inc.

People inherit different versions of any particular gene, and some genes affect how patients process and metabolize medicines. This especially holds true for people with cardiovascular (CV) disease. They may be fast, slow or non-metabolizers and might also react badly (with serious adverse events) to certain drug therapies or not at all.

27 Nov 2013

FDA grants Orphan Drug Designation to CMC Contrast's CMC-001 MRI contrast media

CMC Contrast AB, a privately owned drug development company that is developing a targeted contrast agent for Magnetic Resonance Imaging (MRI), announced today that Orphan Drug Designation has been granted by the US Food and Drug Administration (FDA) for its liver specific contrast agent CMC-001.

27 Nov 2013

Fluxion Biosciences reports first study results from early stage NSCLC patients

Fluxion Biosciences, Inc. announced the presentation of the first pilot study results aimed at isolating circulating tumor cells (CTCs) from early stage non-small cell lung cancer (NSCLC) patients obtained in collaboration with Dr. Max Diehn's lab at Stanford University. CTCs are cells that disseminate from primary tumors and contribute to the spread of the disease to other parts of the body.

From Fluxion Biosciences 27 Nov 2013

Researchers develop prototype spacesuit biosensors to monitor astronauts' health

Kansas State University researchers are improving astronauts' outerwear for outer space. The collaborative team -- which includes electrical and computer engineering professors and more than a dozen students -- envisions a future spacesuit that could monitor astronauts' health and use body heat to power electronics.

27 Nov 2013

UMass Medical School licenses "anti-gal" technology to Agalimmune

The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.

27 Nov 2013

AB SCIEX launches IVD-MS Analyzer CE marked for general in vitro diagnostic use in Europe

Continuing to rapidly expand its presence in the clinical diagnostics field, AB SCIEX, a global leader in analytical technologies, today announced the launch of its AB SCIEX IVD-MS™ Analyzer CE marked for general in vitro diagnostic use in Europe.*

27 Nov 2013

MIT Media Lab develops "nano-camera" that operates at speed of light

A $500 "nano-camera" that can operate at the speed of light has been developed by researchers in the MIT Media Lab.

27 Nov 2013

BUSM & BMC win GCE grant to develop next-generation condom using nanotechnology

The department of radiology at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) is a Grand Challenges Explorations (GCE) winner, an initiative funded by the Bill & Melinda Gates Foundation.

26 Nov 2013

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Bruker Corporation today announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens.

26 Nov 2013

Researchers develop new microsystem for testing drugs to treat epilepsy, MG and cystic fibrosis

Researchers from the University of Southampton, in collaboration with researchers at the University of Quebec at Montreal, have developed a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy.

26 Nov 2013

Purlife inks deal with Canada-based auto warranty company

Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, is proud to announce that its partner, Purlife, has signed a deal with one of Canada's largest automotive warranty companies to make its revolutionary Drivepur Protection System available to a network of 1,200 car dealerships.

26 Nov 2013

New collaborative effort to advance MEMS technologies for key applications

A*STAR Institute of Microelectronics (IME), GLOBALFOUNDRIES Singapore Pte. Ltd., and Masdar Institute of Science and Technology (MI) have entered into a collaboration to develop and advance micro-electro-mechanical systems (MEMS) technologies for automotive, aerospace, consumer, healthcare, industrial, and mobility applications.

26 Nov 2013

Clinicians perform unnecessary Pap tests in certain groups of women, says researcher

For the past ten years, clinicians throughout the United States have been performing unnecessary Pap tests for cervical cancer screening in certain groups of women, according to a researcher from Huntsman Cancer Institute (HCI) at the University of Utah.

26 Nov 2013

DKMS selects Remedy Informatics to provide analytics and pattern recognition technology

Remedy Informatics, Inc., the leading provider of registry-based informatics software for life sciences research and healthcare delivery, announced that DKMS, the world's largest bone marrow donor center, has selected Remedy's informatics solutions to solidify its position as an innovator and leader of hematopoietic stem cell transplantation worldwide.

26 Nov 2013

WTS launches 'Trax: GPS Tracker for Children & Pets'

Wonder Technology Solutions (WTS), a Swedish-based technology startup, has launched Trax: GPS Tracker for Children & Pets, a brilliant new smart device and application that lets users locate their children and pets at anytime and from anywhere.

26 Nov 2013

Device / Technology News

Researchers create breathalyzer that may help control blood sugar

Current laser therapy approaches provide effective treatment for excessive scars

Penn Medicine incorporates automated prediction tool that aims to reduce hospital readmissions

Novel micro-catheter fluorescent dye method to treat aneurysm in deep brain

Bioaxial secures funds to market optical microscopy modules

Genetics and cardiovascular drugs: an interview with Nancy Lurker, CEO of PDI and Paul Kinnon, CEO of Transgenomic, Inc.

FDA grants Orphan Drug Designation to CMC Contrast's CMC-001 MRI contrast media

Fluxion Biosciences reports first study results from early stage NSCLC patients

Researchers develop prototype spacesuit biosensors to monitor astronauts' health

UMass Medical School licenses "anti-gal" technology to Agalimmune

AB SCIEX launches IVD-MS Analyzer CE marked for general in vitro diagnostic use in Europe

MIT Media Lab develops "nano-camera" that operates at speed of light

BUSM & BMC win GCE grant to develop next-generation condom using nanotechnology

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Researchers develop new microsystem for testing drugs to treat epilepsy, MG and cystic fibrosis

Purlife inks deal with Canada-based auto warranty company

New collaborative effort to advance MEMS technologies for key applications

Clinicians perform unnecessary Pap tests in certain groups of women, says researcher

DKMS selects Remedy Informatics to provide analytics and pattern recognition technology

WTS launches 'Trax: GPS Tracker for Children & Pets'

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News